Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003545434 | SCV004265024 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005288979 | SCV005952597 | uncertain significance | not specified | 2025-01-21 | criteria provided, single submitter | clinical testing | The c.438T>G (p.D146E) alteration is located in exon 1 (coding exon 1) of the TACSTD2 gene. This alteration results from a T to G substitution at nucleotide position 438, causing the aspartic acid (D) at amino acid position 146 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |